Recent

% | $
Quotes you view appear here for quick access.

Given ImAŞing Ltd. Şti. Message Board

  • maxschmit777 maxschmit777 Feb 16, 2011 10:39 AM Flag

    Good report

    Worldwide revenues in the fourth quarter of 2010 were a record $44.9 million, a 12% increase from $40 million in the fourth quarter of 2009. Revenues in the Americas region were $27.9 million, including revenues of $5.2 million from the Bravo pH Monitoring System and $4.0 million from sales of Sierra Scientific Instruments, which was acquired in April 2010. In the same period in 2009 revenues in the Americas region were $24 million, including revenues of $4.4 million from Bravo. Revenues in the EMEA region were $11.7 million including $2.0 million from Sierra products. In the same period in 2009, EMEA revenues were $11.3 million. APAC revenues were $5.3 million in the fourth quarter of 2010 compared to $4.7 million in the same period in 2009.

    Worldwide PillCam SB sales amounted to 57,900 capsules in the fourth quarter of 2010, compared to 60,800 in the same period last year. PillCam SB sales in the Americas region were 36,900 in the fourth quarter of 2010 compared to 38,400 in the same period last year. PillCam SB sales in the EMEA region were 14,100 compared to 15,900 in the fourth quarter of 2009, while PillCam SB sales in the APAC region were 6,900 compared to 6,500 in the same period in 2009.

    GIVN attributed lower Pillcam sales in U.S. to overall drop in medical tests, but says sales will pick up with improving economy.